Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
9 METERS BIOPHARMA, INC. | Chief Financial Officer | Common stock | 194K | $44.3K | $0.23 | Sep 14, 2021 | Direct |
Timber Pharmaceuticals, Inc. | Director | Common Stock, par value $0.001 per share | 11.1K | $18.1K | $1.63 | Apr 15, 2023 | Direct |
Timber Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 5.33K | Apr 15, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2023 | 2 | $0 | 4 | Apr 18, 2023 | Director |
TMBR | Timber Pharmaceuticals, Inc. | Dec 15, 2022 | 1 | $4.07K | 4 | Dec 16, 2022 | Director |
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2022 | 2 | $0 | 4 | Apr 19, 2022 | Director |
TMBR | Timber Pharmaceuticals, Inc. | Nov 23, 2021 | 1 | $6.9K | 4 | Nov 24, 2021 | Director |
NMTR | 9 METERS BIOPHARMA, INC. | Sep 14, 2021 | 1 | $18.3K | 4 | Sep 15, 2021 | Chief Financial Officer |
TMBR | Timber Pharmaceuticals, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 6, 2021 | Director |